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INTRODUCTION 
The immune system and its coordinated response are 
shaped by a variety of endogenous and exogenous fac-
tors, modulators and challenges. Sex differences play a 
central role in determining how the male and female 
immune systems are regulated and respond to stimuli. 
One of the most frequent differences is that females 
exhibit more vigorous innate [1, 2], cell-mediated [3], 
and humoral immune responses [4, 5] to antigenic chal-
lenges than males, which can reduce pathogen load and 
accelerate pathogen clearance but can lead to a con-
sequent increase in immune-related pathology [2, 6] 
such as autoimmune or inflammatory diseases [7-9]. In 
the medical field sex refers to the genetic and biological 
status of XX or XY organisms while gender refers to 
the social and cultural differences between females and 
males. As both factors play together, they contribute to 
the immunological dimorphism. [10, 11]. Despite ac-
cumulating evidence support sex-based differences in 
immune responses, in the susceptibility to infectious 
diseases and in the prevalence of autoimmune diseases, 
a majority of immunological studies either do not dis-
aggregate and analyze data by sex or do not report the 
sex of their subjects [12]. The fundamental differences 
in the immune systems of males and females are attrib-
uted not only to differences in sex hormones, but are 
related to X chromosome gene contributions and the 
effects of environmental factors [13, 14]. 
Here we review the main differences in immune sys-
tem biology between males and females, considering 
biological and genetic makeup as well as the role of 
gender as an immunomodulator. Moreover, we review 
sex-based differential immune responses to viral infec-
tion and vaccination. 
SEXUAL DIMORPHISM IN IMMUNITY
It is well known that sexual dimorphism occurs both 
in human and animal models [15]. Males and females 
exhibit the same immune cells but the responses against 
bacteria, virus, parasites, allergens and self-antigen are 
markedly different among the sexes. It is well known, 
that females develop a lower burden of microbial in-
fections by mounting higher and prolonged humoral 
and cell mediated immune responses [3] and gener-
ally mount higher innate immune responses [1, 2] than 
males. The heightened immune response that makes 
females more resistant to infections, however, also ren-
dered them more susceptible to immune-mediated dis-
eases such as autoimmune disorders and inflammatory 
diseases [7-9]. 
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Abstract
Sex/gender significantly contribute to shape the immune responses, contributing to dif-
ferences in the pathogenesis of infectious diseases in males and females, the response 
to viral vaccines and the prevalence of autoimmune diseases. Females typically develop 
higher innate, humoral and cellular immune responses to viral infections and in response 
to vaccine. At the same time, women are more prone to autoimmune diseases and ex-
perience more adverse reactions to vaccination. Hormonal, genetic and environmental 
factors between males and females may affect the immune responses and the sex-related 
outcome of vaccination. Knowledge of the mechanisms involved in sex disparity in im-
mune responses will contribute to identify the ways to reduce adverse reactions in fe-
males and to improve the immune responses in males. This is necessary to adequately 
protect both sexes against the immune-mediated and infectious diseases with the long-
term goal of personalizing the therapies for males and females. 
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Innate immunity
Innate immunity, the first line of defense against in-
fections, is rapid and short lived and is not characterized 
by immunological memory. Granulocytes, monocytes, 
macrophages, dendritic cells (DCs) and natural killer 
(NK) cells are acknowledged to be involved in innate 
immunity and their function includes phagocytosis, in-
duction and regulation of immune response, destruction 
of infected cells and cytokine production to amplify the 
non-specific and specific immune responses. Several dif-
ferences exist between females and males in their innate 
immune responses including differences in cell number 
and activity, as well as in cytokine production. Differ-
ences between the sexes are shown in the induction of 
genes associated with toll-like receptor (TLR) pathways 
and antiviral type I interferon (IFN) responses with cells 
from females showing an higher level of expression of 
these molecules than cells from males [4, 16]. More re-
cently, Griesbeck M et al. demonstrated that plasmacy-
toid DCs derived from females, produced significantly 
more IFN-a in response to TLR7 ligands than plasma-
cytoid DCs derived from males, resulting in stronger 
immune activation [17]. It has been demonstrated that 
females show a higher phagocytic activity of neutrophils 
and macrophages and antigen-presenting cells (APC) 
are more efficient respect to APC from males [18]. In 
contrast, males have an increased NK cells activity and 
produce higher levels of pro-inflammatory cytokines, 
such as IL-6 and TNFa by monocytes and macro-
phages, although contrasting data are reported in this 
regard [18, 19]. It has been reported that male mono-
cytes stimulated with LPS showed an increased IL-12 
secretion compared to female monocytes [19].
Acquired immunity
Acquired immune response develops later com-
pared with innate response, persists longer, generates 
memory and is characterized by specificity. T and B 
lymphocytes, the cellular components of the acquired 
immunity, originate from a common bone marrow stem 
cell. T cells represent the main mediators of the cellu-
lar immune response while B cells are the mediators of 
the humoral immune response. Usually, females exhibit 
more vigorous humoral responses and cell mediated 
immune responses to antigenic stimulation, vaccina-
tion, and infection than do males [4, 20]. Both basal 
levels of Ig [21] as well as antibody responses to viruses 
and vaccines are higher in women than men [4, 5, 20]. 
Moreover, females have on average higher frequency 
of circulating CD4+ T cells than men and clinical stud-
ies reveal that males have lower CD3+ and CD4+ T cell 
counts, CD4+ to CD8+ T cell ratios, and helper T cell 
type 1 (Th1) responses than females [22, 23]. Cytokine 
productions in response to infections is enhanced in fe-
males compared with males [15]. 
BIOLOGIC MECHANISMS OF SEX 
DIFFERENCES
Immunological differences between the sexes have 
been focused on two main influences: endocrine-im-
mune interactions as well as genetic differences be-
tween the sexes. 
Immunomodulatory effects of sex hormones 
Sexual hormones, i.e. estrogen, progesterone, and 
testosterone affect immune cells both quantitatively 
and qualitatively modulating their coordinated re-
sponses. Sex steroids alter immune cells performance 
through the binding to specific receptors, both nuclear 
and non-nuclear.
The innate immune system is suppressed by estrogen. 
In particular, estrogen signaling inhibits the transcrip-
tion of the Fcγ RIIIA gene thus reducing the ability 
of monocytes to produce IL-1β, IL-6 and TNF [24]. 
Furthermore, it has been shown that the production of 
these cytokines is decreased during the follicular phase 
of the ovarian cycle, and it is increased in the luteal 
phase [18]. 
Estrogen also suppresses neutrophils in a bipha-
sic fashion: during menstruation there are decreased 
numbers of circulating neutrophils [25], in the follicu-
lar phase neutrophil endometrial infiltration increases 
[26], and during post-ovulation as the early corpus lu-
teum develops, there is further neutrophil infiltration 
[27]. Estrogen boosts the expression of nitric-oxide 
synthase [28] and therefore of nitric oxide [29], and 
it impairs the chemotactic ability of neutrophils in 
culture. Moreover, chemotaxis of neutrophils appears 
enhanced by progesterone, while testosterone had no 
modulating effect [29]. Molloy and colleagues have 
demonstrated decreased neutrophil apoptosis in wom-
en compared to men [30].
Elevated levels of progesterone and estrogen affect 
NK cell activity. High dosage of estrogen induces a sup-
pressive activity down-regulating the expression of NK 
cells activating receptors CD69, NKp46, NKG2DL 
and 2B4 [31], while low dosage shows no effect. 
Estrogen also has a significant impact on the differ-
entiation and activation of DCs. Bengtsson et al. evalu-
ated the effect of estrogen on human monocyte-derived 
DCs. Exposure of the immature DCs to estrogen en-
hanced their IL-6, IL-8 and MCP-1 secretion and in-
creased their T lymphocyte stimulatory capacity [32]. 
The ability to increase T cell stimulation was confirmed 
and explained by an estrogen-driven up-regulation of 
MHC II in DCs [33]. 
Hormonal influences on the function of B lympho-
cytes have been quantified analyzing immunoglobulin 
levels. It is well known that females produce more el-
evated circulating levels of antibodies than males [21]. 
Kanda and colleagues [34] reported that estrogen en-
hances IgG and IgM production in both males and fe-
males, directly and stimulating monocytes to produce 
IL-10. Testosterone, on the other hand, appears to in-
hibit IgM and IgG production both directly and indi-
rectly by reducing the production of IL-6 by monocytes 
[35]. These hormonal influences can account for the 
discrepancies between females and males not only in 
autoimmune diseases [4], but also in response to infec-
tious diseases and to vaccination. It has been reported 
that estrogen increases the expression of CD22, SHP-1 
and Bcl-2, the mediators of B-cell survival, while im-
pairs mediators of B-cell apoptosis such as PD-1. This 
could trigger the survival of auto-reactive B-cell clones 
leading to autoimmune diseases [36, 37]. Testosterone 
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plays an opposite role impairing B-cell differentiation 
in response to pokeweed mitogen in human PBMC in 
vitro [38]. 
T regulatory (Treg) cells exert immunoregulatory 
functions controlling the expansion of the peripheral T 
cell pool and its response to infections and maintaining 
self-tolerance controlling the expansion of auto-reactive 
T cell clones. Estrogen at high concentration (e.g. dur-
ing pregnancy or the periovulatory phase of the men-
strual cycle) positively influences Treg cells, increasing 
their frequency and number [39]. Therefore, estrogen, 
driving the expansion of the Treg compartment, could 
contribute to the increased incidence of autoimmune 
diseases in women [40]. 
Estrogen controls T cell homing by increasing the 
expression of certain chemokine receptors in CD4+ 
T-cells such as the CC-chemokine receptors, CCR5 
and CCR1 [41]. Estrogen also regulate Th1 and Th2 
responses in a bi-phasic manner during the menstrual 
cycle in females. Indeed, low doses of estrogen, accom-
panying menstruation and during the luteal phase skew 
the Th response towards a Th1 polarization with asso-
ciated increased cell-mediated immunity, whereas high 
doses of estrogen during the follicular phase, unbalance 
the Th cell differentiation toward a Th2 phenotype and 
associated humoral responses [42].
It has been reported a relationship among commen-
sal gut microbiome, immune responses, and host hor-
mones. Recent finding suggest that the hormonal status 
of the host can shape microbiome composition and re-
ciprocally, the microbiome may exert various influence 
over host sex hormone levels, contributing to the dif-
ferences in the immune response between females and 
males [43]. 
The role of sex chromosomes-linked genes and genetic 
polymorphisms
As a general rule, the gender immunological dimor-
phism is consequence of direct effect of sex hormones. 
However, it is well know that a natural difference of ex-
pression of Y and X-linked genes also contributes to sex 
differences in the immune response [44]. More than 
1000 genes are mapped on the X chromosome versus 
only 100 on the Y chromosome and many genes on the 
X chromosome are immune-related coding for proteins 
involved in immune functions. Furthermore, naturally 
occurring mutations in one gene copy might produce 
two distinct alleles with different immunomodulatory 
capacity. These immune-related genes code for proteins 
such as TLR7 and TLR8, ɣ-chain subunit common to 
receptors for IL-2, IL-4, IL-7, IL-9, IL-15, IL-21 and 
transcriptional factors such as Foxp3 [13]. Females 
have a higher expression of TLR7 [45] respect to males, 
pDCs from females produce more IFN-a in response 
to TLR7 stimulation than pDC from males [46] and sex 
hormones, as written above, can modulate the IFN-a 
production in response to TLR7 ligands [17]. Further-
more, the expression of X-linked genes may be affected 
by X-linked micro-RNAs (miRNAs), which, regulat-
ing post-transcriptional mRNA gene expression, play a 
central role in maintaining immunological homeostasis. 
The X chromosome contains a higher number of miR-
NAs than autosomal chromosome, while Y chromo-
some contains only two miRNAs. It is now clear that 
miRNA located on the X chromosome, can contribute 
to sex-specific development of immuno-mediated dis-
eases [47]. A dysregulated miRNA expression and/or 
function has been associated with various autoimmune 
diseases including systemic lupus erythematosus, rheu-
matoid arthritis and multiple sclerosis and estrogen may 
contribute to the pathogenesis of autoimmune disease 
such as systemic lupus erythematosus via the regulation 
of miRNA expression [48]. 
Mutations and/or polymorphisms of immune-related 
gene on X chromosome may be critical determinants 
of immune system diseases. Female carry two chro-
mosomes, one from each parent, whereas males carry 
one X chromosome inherited from the mother and 
one from the father. The X chromosome inactivation 
provides dosage compensation from X-linked genes be-
tween XX females and XY males: in a female, approxi-
mately half of the cells expresses genes derived from 
the maternal X chromosome and the other half express 
genes derived from the paternal X chromosome. Thus, 
deleterious mutations that occur in an X chromosome-
linked gene makes male more susceptible to clinically 
relevant diseases, whereas the phenomenon of X inac-
tivation in females protects them from immune dys-
regulation.
GENDER DIFFERENCES
In addition to biological differences, we discuss the 
immunomodulatory role of gender. Gender interacts 
with biological factors, such as hormones and genet-
ics, in the exposure, development and outcomes of the 
immune response. Gender refers to the differences 
between males and females regulated by cultural and 
social factors that, involving all areas of human life, 
consequently affect the different steps of the immune 
response. Exposure to various types of antigens, access 
to health promotion programs and health care, as well 
as prioritization of health needs, affect the different re-
sponse of females and males to immunologic challenges 
[49]. Differences in the social expectations in men and 
woman in the household and in the workplace deter-
mine different exposure patterns to antigens. For exam-
ple, the exposure to asbestos in construction works, a 
profession mostly performed by males, increases the in-
cidence of mesothelioma, while in many cultures, wom-
en spend more time at home and thus are more exposed 
to indoor pollution from smoking and heating. Food in-
take and food composition also affect the immune func-
tion and in many areas of the world, the inadequate nu-
trition is more frequent in the woman [50]. Women in 
developing countries are frequently confronted with a 
myriad of socio-cultural factors which negatively impact 
on physical well-being and accessibility to appropriate 
health care services. From an immunological viewpoint, 
a lack of resources determine less access to antibiotics 
and chemotherapies, affecting infective, rheumatologic 
or cancer diseases. Poverty is one major gender bias in 
access to all procedures of health care in any society, 
thus should be considered an indirect female immuno-
modulatory factor.
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SEX INFLUENCES THE RESPONSES TO  
AND OUTCOME OF VIRAL INFECTIONS
Rodent studies have shown that males are more sus-
ceptible to infections by several pathogens (bacteria, 
parasites and viruses) and that this difference related 
to sex hormones [51]. Actually, it has long been rec-
ognized [52] that the prevalence and susceptibility to 
some viral infections are higher in male than in female, 
as in the case of Hepatitis B and C viruses, HIV, Hanta-
virus, West Nile Virus infections, influenza viruses, that 
are more prevalent and intense in male than in female 
infected patients. However, the outcome and course of 
viral infections are worse in women than men, although 
the mortality is often higher in male patients [53]. The 
mechanisms involved in the sex differences in viral in-
fections are mostly unknown.
According to the above described sex/gender differ-
ences in immune responses, women have a reduced sus-
ceptibility to viral infections because they mount stron-
ger immune responses than men. There is a growing 
body of evidence from literature [3, 10] showing that 
both innate and adaptive immune responses to viral in-
fections differ between males and females. In particular, 
the immune responses toward viruses are usually more 
intense in females than in males. As a consequence, 
women are more immune-reactive and more prone to 
undergo immune-pathogenic effects of viral infections, 
as well as to develop increased symptoms in viral infec-
tions compared to male infected patients. When a virus 
infects and encounters the host immune system, induc-
tion of the innate immune response, including the APCs 
activity and the initial inflammatory response mediated 
by cytokines, chemokines and IFN production, is more 
elevated in female than in male [53]. Following clear-
ance of virus, during the return to homeostasis, females 
can maintain elevated immune responses resulting in an 
increased risk of immune-pathologies; in males, in con-
trast, lower antiviral immune responses can result in an 
increased risk of virus persistence compared to females.
THE RESPONSES TO VACCINATION DIFFER 
BETWEEN SEXES
Women have been historically under-represented in 
clinical trials, including vaccine clinical trials [53], that, 
as consequence, may have led to an inaccurate dosage 
of vaccines for women. The responses to vaccination 
have been reported to differ between sexes [54]; how-
ever, vaccines are commonly administered in a same 
way to male and female recipients. With regard to this, 
few years ago, Engler RJ and collaborators showed that 
young women receiving half dose of the seasonal in-
fluenza vaccination generated a stronger antibody re-
sponse that was equivalent to that of men vaccinated 
with full dose [55]. Moreover, despite higher morbidity 
and mortality during influenza pandemics, probably due 
to elevated induction of pro-inflammatory cytokines 
and chemokines, women showed a better response to 
influenza vaccination in terms of higher levels of neu-
tralizing antibodies [56]. Besides influenza vaccination 
response, sex-related differences have been observed in 
immunogenicity and effectiveness for several other vac-
cines, such as Hepatitis A and B [57], measles [58], 
yellow fever [59], Herpes simplex 2 [60]. Yellow fever 
vaccine is an interesting example, since it has been re-
ported to elicit a stronger response in females, through 
the up-regulation of TLR–associated genes, that acti-
vate IFN production only in women [61]. In the case 
of Hepatitis B vaccination in children and adults, anti-
HBV antibody titers are higher in females than males 
[62, 63]. Similarly, the antibody responses to seasonal 
trivalent inactivated influenza vaccine have been re-
ported to be higher in women than in men and female 
mice also mount higher neutralizing antibody responses 
against either sub-lethal primary infection and to vac-
cination than male mice [64, 65]. However, it is not 
known whether the enhanced immune responses to 
vaccines in females are associated to a more efficacy or 
to long-lived protection.
Facing the female immune-privilege in response to 
vaccination, women experience worse and more often 
side effect of vaccination, probably related to higher 
inflammatory and cellular immune responses in female 
recipients than in males. This was reported with a mea-
sles vaccination trial in Guinea-Bissau and Senegal in 
1990s, during which only female recipients of the vac-
cine had twofold increase of mortality compared with 
the standard vaccine [66]. In Italy, the official report of 
post-marketing vaccines surveillance (AIFA 2013) also 
reported a 56% of adverse reactions in females vs 46 
% in males towards all the recommended vaccinations. 
With regard to the mechanisms involved, based on 
the above described effects of sex hormones on the im-
mune system it is conceivable that they play a role in 
the sex disparity of response to vaccines. In fact, it has 
been reported that men with high testosterone levels 
mount lower titers of neutralizing antibodies to influ-
enza vaccination compared to men with low levels of 
testosterone, suggesting an immunosuppressive role 
for testosterone. Conversely, estrogen at physiological 
concentration, can stimulate antibody production by B 
cells including the response to influenza vaccine admin-
istered to mice [67, 68].
In addition to the hormonal influences, sex differenc-
es observed in immune responses between pre-puberal 
boys and girls, and in post-menopausal women, sug-
gest a different mechanism. As illustrated in a previous 
paragraph, the X chromosome contains genes encoding 
for immune-related molecules and transcription fac-
tors (i.e. for IL-2 receptor gamma chain, IL-3 receptor, 
TLR7, -8, CD40 ligand, FOXP3 etc.), that implicates 
that X chromosomes contain determinants of immune-
competence. As a consequence of the XX genetic com-
position of female and of XY in male any damaging 
mutation or polymorphism to X-linked genes are more 
likely to have immune consequences in male compared 
to female [69]. With regard to this, it has been reported 
that girls generate higher antibody responses than boys 
in response to the mumps vaccine as a consequence of 
the polymorphisms in the cytokine receptor genes IL-
12 RB1 and IL-12 RB2 [70]. Androgen receptor is also 
encoded on X chromosome. The sex hormones recep-
tors bind to their hormone response element upstream 
of the target genes and recruit methylation enzymes, 
thus influencing epigenetic regulation of gene expres-
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sion [71]. This mechanism, together with the different 
gene composition between XX and XY, probably affects 
the sex disparities in immune responses to vaccination.
More recent studies have provided insights into the 
relation between the microbiota and the host immune 
responses, as stated above. It is known that bacteria can 
metabolize sex hormones with consequent direct influ-
ence on the immune response, in sex-specific manner. 
The different efficacy of oral vaccines against poliovirus, 
rotavirus and cholera in different geographical areas 
have been ascribed to differences in the microbiota of 
the recipients [72]. Some studies have shown that pro-
biotics given together with vaccines, such as diphtheria, 
tetanus, cholera, Hepatitis B, improved the antibody 
responses [73]. Although these results are intriguing, 
they deserve further studies.
CONCLUSIONS
Sex-specific determinants of immunity such as the ef-
fects of sex hormones, sex-chromosome-encoded genes 
and environmental exposure directly contribute to the 
immune cell repertoire in response to a specific insult. 
These factors may influence DNA methylation, expres-
sion levels of miRs, and chromatin remodeling. More-
over, these sex-specific determinants regulate microbi-
ome composition and potentially shape immune cell 
functional profile, through bidirectional relationships. 
The consequences of changed immune cell phenotype 
affect sex-specific responses to vaccination, risk for au-
toimmune disorders and susceptibility to pathogens.
Therefore, the therapeutic intervention strategies 
against infections and autoimmune diseases must take 
these differences into account to provide optimal dis-
ease management for both sexes. Future biomedical 
studies need to report the sex of cells, animals and sub-
jects to improve the understanding of the pathogenesis 
of diseases and thus personalize the therapies for males 
and females. The studies so far available on sex different 
responses to anti-viral therapy and prophylaxis are lim-
ited and suggest the need for additional basic biomedi-
cal research in this area.
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